pegpH20 Ph 1b high Hyaluron grp Med Oversll Surv- next best ever 333- Folfirinox
I wonder fezzy... did pegph20 ever get an orphan drug designation in pancreatic cancer?... aloha K
No, I don't think any drug could because Panc Ca is too common- so FDA doesn't need to entice Pharma to target it with market exclusivity.
Did she say median survival is 529 days or is that best response to date? How many patient in all? Thanks for sharing.
Her chart showed 529 -"not mature" -Frist said same on Nov 5 - 568 d - sometime later Dara matured- prior to Q4 call - check ESMO poster on Halo site for exact numbers of pts
529 days median OS, n=17
Sentiment: Strong Buy
And, Folfirinox is potentially highly toxic with serious side effects -- this places severe limitations on its use.
MFolfirinox green bar M is import litany- no toxic 5FU infusion - better tolerated
Agreed. CEO Helen Torley reports 529 days.
Yup, that is what I was referring to on slide 10.
Did you see slide 10 from today?